Olympus Medical Group parent Olympus has launched SeleCT Connect, a new program that makes its SeleCT quantitative CT analysis service available to U.S. healthcare facilities through Nuance Communications' Nuance AI Marketplace.
The service helps users determine which patients are eligible for treatment with its Spiration Valve System for treating chronic obstructive pulmonary disease patients. It is a partnership between Olympus, artificial intelligence (AI) software developer Imbio, and Nuance, according to the firm.
